Procognia (Israel) signed a binding three-year letter of intent with Cytech – a Hong-Kong based distributor of life sciences products – for the exclusive distribution of Procognia’s blood sugar analysis kits in China and Taiwan. According to the deal, Procognia will receive a percentage of sales and revenue from the analysis services. The Glycoscope kit is designed for pharmaceutical companies and research laboratories to identify and monitor the structure of sugars in proteins during the development and production of biological drugs and vaccines, as well as stem cell research. View and share
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments